BusinessMedicare Administrative Contractors Finalize Local Coverage Determinations for Immucor PreciseType® HEA TestBy Nasdaq OMXApr 4, 2016, 8:09 PM UTC
BusinessResults from Vericel’s Positive Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T Presented Today at ACC and Published in The LancetBy Nasdaq OMXApr 4, 2016, 3:45 PM UTC
BusinessAdvaxis to Present at the 3rd Annual Jefferies Immuno-Oncology SummitBy Nasdaq OMXApr 4, 2016, 1:05 PM UTC
BusinessCytokinetics Announces Start of Phase 2 Clinical Trial of Omecamtiv Mecarbil in Japanese Subjects With Heart FailureBy Nasdaq OMXApr 4, 2016, 11:30 AM UTC
BusinessAxsome Therapeutics to Present at the 15th Annual Needham Healthcare ConferenceBy Nasdaq OMXApr 4, 2016, 11:00 AM UTC
BusinessFlexion Therapeutics Announces Presentation of Results From Pivotal Phase 2b and Phase 3 Clinical Trials for Zilretta™ at Osteoarthritis Research Society International (OARSI) 2016 World CongressBy Nasdaq OMXApr 4, 2016, 11:00 AM UTC
BusinessCuris Announces Publication of CUDC-907 Phase 1 Clinical Trial Data in Lancet OncologyBy Nasdaq OMXApr 4, 2016, 11:00 AM UTC
